AzTrials
AzTrials

Third Molar ImpactionNCT06098885

The Effect of Different Treatment Modalities of Class II Malocclusion on Upper Third Molars.

An observational study of Third Molar Impaction, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

What is the effect of the different treatment modalities (distalization versus upper premolar extraction) of class II malocclusion on the position, inclination and incidence of impaction of the upper third molars? Read more about this study

Who is it for?
Ages 16 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Third Molar Impaction
What is being tested?
extraction orthodontic treatment
How many people
46 participants
Where
1 siteEgypt
Study dates
4 Sep 2021to 4 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Study population: • Egyptian Adolescent males and females (16 -18 years)

Who may be able to join

  • Adolescent males and females (16 -18 years) with Bilaterally developing maxillary third molars. Not more than two thirds of the root development of the third molars had taken place.
  • Class II malocclusion cases that were treated by 1) maxillary premolar extraction with a moderate anchorage requirement and achieved full unit class II molar relationship or 2) Distalization treatment plan and class I molar relationship was achieved.
  • Patients with high-quality pre- and post-treatment radiographs.
  • Normal or increased vertical dimension.

Who cannot join

  • Maxillary Premolar extraction cases requiring maximum anchorage preparation.
  • Low vertical dimension.
  • Patients without dentofacial deformities, severe facial asymmetries, microdontia or hypodontia.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Amira Aboalnaga

    Cairo, 12588

Other trials in Egypt

About this study

Official title: The Effect of Different Treatment Modalities of Class II Malocclusion on Upper Third Molars: A Retrospective Longitudinal Study

What is the effect of the different treatment modalities (distalization versus upper premolar extraction) of class II malocclusion on the position, inclination and incidence of impaction of the upper third molars?

Read the detailed description

What is the effect of the different treatment modalities (distalization versus upper premolar extraction) of class II malocclusion on the position, inclination and incidence of impaction of the upper third molars? Pico P: Adolescent patients with class II malocclusion having bilateral developing upper third molars.

I: bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

C: distalization orthodontic treatment. O: Primary: angulation of the maxillary third molars.

Being tested
extraction orthodontic treatment
Keywords
distalization, premolar extraction, upper third molar, impaction of third molar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • extraction orthodontic treatmentOther

    bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.

Study groups in NCT06098885
Study groupRoleWhat they receive
extraction treatmentpatients treated with bilateral upper first premolar extraction orthodontic treatment with moderate anchorage.
Receives: Other: extraction orthodontic treatment
distalization treatmentpatients treated by distalization orthodontic treatment.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The angulation of the maxillary third molars.

    the angle between the long axis of the third molar and the palatal plane

    Measured: up to 24 weeks.

Secondary outcomes (2)
  1. The vertical position of the third molars

    the vertical position of the third molar relative to the second molar measured using Archer classification tool. (qualitative measure)

    Measured: up to 24 weeks

  2. The mineralization status of the third molars

    the amount of calcified tissues of the third molar measured using Demirjian classification method

    Measured: up to 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Oct 2023
  2. Study start4 Sep 2021
  3. Primary completion4 Jun 2023
  4. Study completion4 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Retrospective
Enrolment
46 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06098885
Sponsor's protocol ID
CEBD-CU-2021-9-7
Status last verified
Oct 2023
First submitted
8 Sep 2021
Last updated
25 Oct 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Third Molar Impaction, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The angulation of the maxillary third molars. (time frame: up to 24 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in